3-(4-fluorophenyl)-2-methyl-3-oxopropanenitrile | 1094267-29-4

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 3-(4-fluorophenyl)-2-methyl-3-oxopropanenitrile
• CAS: 1094267-29-4
• 化学式: C₁₀H₈FNO
• 分子量: 177.178
• InChiKey: USLUDEAOTCLSEN-UHFFFAOYSA-N

物化性质

• 沸点：
  314.0±22.0 °C(Predicted)
• 密度：
  1.166±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  40.9
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  3-(4-fluorophenyl)-2-methyl-3-oxopropanenitrile 在 一水合肼 、 溶剂黄146 作用下， 以 乙醇 为溶剂， 反应 3.0h， 生成
  参考文献：
  名称：

  Discovery and characterization of a novel 7-aminopyrazolo[1,5-a]pyrimidine analog as a potent hepatitis C virus inhibitor

  摘要：

  We describe a novel 7-aminopyrazolo[1,5-a]pyrimidine (7-APP) derivative as a potent hepatitis C virus (HCV) inhibitor. A series of 7-APPs was synthesized and evaluated for inhibitory activity against HCV in different cell culture systems. The synthesis and preliminary structure-activity relationship study of 7-APP are reported. (C) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2012.10.123
• 作为产物：
  描述：

  对氟苯甲酸乙酯 、 丙腈 在 sodium 作用下， 以 乙醇 为溶剂， 生成 3-(4-fluorophenyl)-2-methyl-3-oxopropanenitrile
  参考文献：
  名称：

  Discovery and characterization of a novel 7-aminopyrazolo[1,5-a]pyrimidine analog as a potent hepatitis C virus inhibitor

  摘要：

  We describe a novel 7-aminopyrazolo[1,5-a]pyrimidine (7-APP) derivative as a potent hepatitis C virus (HCV) inhibitor. A series of 7-APPs was synthesized and evaluated for inhibitory activity against HCV in different cell culture systems. The synthesis and preliminary structure-activity relationship study of 7-APP are reported. (C) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2012.10.123

文献信息

• [EN] SUBSTITUTED 6-(1H-PYRAZOL-1-YL)PYRIMIDIN-4-AMINE DERIVATIVES AND USES THEREOF<br/>[FR] DÉRIVÉS DE 6- (1H-PYRAZOL-1-YL) PYRIMIDIN-4-AMINE SUBSTITUÉS ET LEURS UTILISATIONS
  申请人：BAYER AG

  公开号：WO2018069222A1

  公开（公告）日：2018-04-19

  The present invention covers substituted 6-(1H-pyrazol-1-yl)pyrimidin-4-amine compounds of general formula (I) as described and defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds, and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of cardiovascular and renal diseases, as a sole agent or in combination with other active ingredients.

  本发明涵盖了通式（I）所述和定义的取代6-(1H-吡唑-1-基)嘧啶-4-胺化合物，以及制备该化合物的方法，用于制备该化合物的有用中间体化合物，包含该化合物的药物组合物和组合物，以及利用该化合物制造用于治疗或预防疾病的药物组合物，特别是用作唯一活性成分或与其他活性成分组合使用，用于治疗和/或预防心血管和肾脏疾病。
• Enantioselective dearomative [3+2] annulation of 5-amino-isoxazoles with quinone monoimines
  作者：Hui Liu、Yingkun Yan、Jiayan Zhang、Min Liu、Shaobing Cheng、Zhouyu Wang、Xiaomei Zhang

  DOI：10.1039/d0cc05807f

  日期：——

  The first enantioselective dearomative [3+2] annulation of 5-amino-isoxazoles with quinone monoimines was realized using a chiral phosphoric acid as catalyst. Various novel (bridged) isoxazoline fused dihydrobenzofurans bearing two continuous quaternary stereocenters were achieved in moderate to good yields (up to 94%) with moderate to good enantioselectivities (up to 98% ee). The absolute configurations

  使用手性磷酸作为催化剂，实现了5-氨基-异恶唑与醌单亚胺的首次对映选择性脱芳香性[3 + 2]环化反应。具有中等至良好的对映选择性（高达98％ee）的中等至良好的产率（高达94％）获得了具有两个连续的季立式立体中心的各种新颖的（桥接的）异恶唑啉稠合的二氢苯并呋喃。通过X射线晶体结构分析确定了两种产物的绝对构型，并提出了合理的反应机理。
• Sc(OTf) ₃ ‐Catalyzed Dearomative [3+2] Annulation of 5‐Aminoisoxazoles with Quinone Imine Ketals or Quinone Monoacetals
  作者：Yingkun Yan、Min Li、Min Liu、Min Huang、Lianyi Cao、Wenzhe Li、Xiaomei Zhang

  DOI：10.1002/ejoc.202200067

  日期：2022.5.13

  Dearomative [3+2] annulation of 5-amino-isoxazoles with quinone imine ketals (QIKs) and quinone monoacetals (QMAs) provided various indoline- or 2,3-dihydrobenzofuran-fused isoxazolines in moderate to good yields with excellent diastereoselectivities.

  5-氨基异恶唑与醌亚胺缩酮 (QIK) 和醌单缩醛 (QMA) 的脱芳构 [3+2] 环化反应提供了各种二氢吲哚或 2,3-二氢苯并呋喃稠合的异恶唑啉，产率中等至良好，具有优异的非对映选择性。
• Substituted 6-(1H-pyrazol-1-yl)pyrimidin-4-amine derivatives and uses thereof
  申请人：Bayer Aktiengesellschaft

  公开号：US11208400B2

  公开（公告）日：2021-12-28

  The present invention covers substituted 6-(1H-pyrazol-1-yl)pyrimidin-4-amine compounds of general formula (I) as described and defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds, and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of cardiovascular and renal diseases, as a sole agent or in combination with other active ingredients.

  本发明涉及本文所述和定义的通式（I）的取代 6-(1H-吡唑-1-基)嘧啶-4-胺化合物、制备所述化合物的方法、用于制备所述化合物的中间体化合物、包含所述化合物的药物组合物和组合物，以及使用所述化合物制造治疗或预防疾病，特别是治疗和/或预防心血管疾病和肾脏疾病的药物组合物，作为单独制剂或与其他活性成分组合使用。
• SUBSTITUTED 6-(1H-PYRAZOL-1-YL)PYRIMIDIN-4-AMINE DERIVATIVES AND USES THEREOF
  申请人：Bayer Aktiengesellschaft

  公开号：EP3526212A1

  公开（公告）日：2019-08-21